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Highlights 
 
 A simple method for fast (~20 s) inactivation of biocatalysts under flow conditions. 
 A microfluidic device capable of accommodating a wide range of inactivation temperatures. 
 A microfluidic system capable of integration in a modular platform. 
 Characterization of the microfluidic device using computational fluid dynamics. 
 
 
Abstract 
The need for fast and comprehensive characterization of biocatalysts has pushed the 
development of new screening platforms based on microfluidics, capable of monitoring several 
parameters simultaneously, with new configurations of liquid handling, sample treatment and 
sensing. Modular microfluidics allows the integration of these newly developed approaches in 
a more flexible way towards increasing applicability of the microfluidic chips to different types 
of biocatalysts and reactions. A highly relevant operation in such a system is biocatalyst 
inactivation, which can enable the precise control of reaction time by avoiding the 
continuation of the reaction in another module or connecting tubes. Such control is important 
when different modules of reactors and/ or sensing units are used and changed frequently. 
Here we describe the development, characterization and application of a module for rapid 
enzyme inactivation. The thermal inactivation platform developed is compared with a 
standard benchtop ThermoMixer in terms of inactivation efficiency for glucose oxidase and 
catalase. A higher activity loss was observed for enzyme inactivation under flow conditions 
(inactivation achieved at 120 s residence time at 338 K and 20 s residence time at 353 K) 
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which indicated a high heat transfer to the fluid under dynamic conditions. Moreover, partial 
deactivation of the enzymes was observed for the continuous thermal inactivation module, 
when activity measurements were performed after 1 and 2 days following inactivation. The 
thermal inactivation unit presented can be easily integrated into modular microfluidic 
platforms and can be a useful addition for enzyme characterization and screening. 
 
List of Abbreviations 
TEM Thermoelectric modules or peltier elements 
MW Microwave 
IR Infrared 
RF Radiofrequency 
MFH Magnetic fluid hyperthermia 
PCR Polymerase chain reaction 
DCHBS Sodium 3,5-dichloro-2-hydroxy-benzenesulfonate 
4-AAP 4-aminoantipyrine 
PP Polypropylene 
PTFE Polytetrafluoroethylene 
GOx Glucose oxidase 
Cat Catalase 
d Day(s) 
HPLC High throughput liquid chromatographer 
ThermoMixer MRH11 Heating ThermoMixer 
CFD Computational fluid dynamics 
Re Reynolds number 
FAD Flavin adenine dinucleotide 
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Introduction: 
The study of the influence of temperature on biological systems is a standard optimization 
procedure in current biotechnological processes [1]. As with other operation parameters, 
temperature is studied in order to obtain the value at which a certain enzyme or organism 
operates at the maximum rate. An enzyme’s temperature operational range is usually a good 
indicator of its structural robustness and how well it will perform under industrial process 
conditions. Enzyme temperature persistence or resistance to denaturation, for example, has 
provided good insight into the structural factors leading to enzymatic increased stability [2], 
which depends, among other factors, on enzyme mobility and folding mechanisms [3]. 
Enzymes tend to fold in conformations which are the most thermodynamically stable at the 
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prevailing environmental conditions[4]. However, for most enzymes, the native active state is 
only marginally more stable than the inactive state, due to the higher conformational entropy 
(conformational freedom) of the latter [4]. Enzyme inactivation can occur through several 
mechanisms, such as protein aggregation, disruption of the polypeptide chain, dissociation of a 
prosthetic group from the active site or subunit dissociation [4,5], resulting in loss of 
conformational structure (denaturation) and functional activity (inactivation). The 
denaturation process can be caused or initiated through a variety of process conditions (e.g. 
elevated temperature, extreme pH, high pressure) or solvents (e.g. Guanidinium chloride, 
urea) [4-7]. Denaturation tends to occur in two steps, where first conformational changes occur 
that lead to protein denaturation or inactivation, and then the denatured proteins aggregate 
through non-covalent interactions [1,5–8]. 
 
Due to its influence on protein conformation, temperature has been extensively used to 
inactivate or deactivate enzymes and organisms. Thermal denaturation occurs by the loss of 
ordered secondary and tertiary structure towards increased entropy due to random and fast 
cooperative intramolecular movements that occur above a certain temperature (which depends 
on the environmental conditions) [9]. It has been extensively used to stop reactions (e.g. avoid 
enzymatic degradation in cells or tissue samples [10]), perform protein conformation studies, 
inactivate pathogens in infectious samples (through protein denaturation [10]), or to ensure no 
microbial growth [11] or degradation of food [12]. It is thus highly relevant that platforms for 
characterization and screening of biocatalysts contain a unit for thermal studies and/or 
inactivation with good temperature control. 
 
Most research laboratories use conventional convective heating, such as water baths, oil baths 
or hot plates, as heating or inactivating strategies. However, these methods have several 
issues. For instance, non-uniform temperature distribution between the heating surface and 
the bulk of the sample or the time required to reach the set inactivation temperature. 
Microfluidics can solve these issues, enabling a rapid and more controlled heat transfer to the 
bulk of the sample, due to the small channel dimensions and available heating strategies 
alternatives.  
 
Conductive heating at a microscale can be achieved with a variety of strategies, either by 
integrating heating elements directly within the platform or by using external heating 
elements. Integrated heating has been achieved through the use of exothermic reactions in 
parallel microchannels in contact with the main channel [13], but also by on-channel 
microfabrication of resistors and thin-film resistors [14–17] or metal wires [13]. External 
heating elements can be hotplates, readily available in most laboratories, but lately 
thermoelectric modules (TEM) or Peltier elements have gained relevance since they allow a 
good control of the applied temperatures and are easily connected with existing electronic 
components. Peltier elements are now relatively ubiquitous in benchtop analytical equipment 
for temperature control [18], but are also increasingly used in microfluidic applications 
[13,19], being employed in applications that require a high degree of temperature control with 
fast switching between temperatures [19,20].  
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Other (non-contact) heating strategies have also been applied at a microscale, some of them 
used in industrial applications. Microwave (MW) dielectric heating enabled higher 
thermocycling rates in PCR applications [13] as well as accelerated reactions [21] compared to 
integrated heating [13,22,23]. Infrared (IR) heating is another example of an industrially-used 
heating strategy that has also been applied at the microscale [13,24], with greater emphasis 
on PCR systems [25]. Radiofrequency (RF) heating for example, which is commonly used on an 
industrial scale in the food industry, has been used at a microscale to perform magnetic fluid 
hyperthermia (MFH) on cells [26]. In this technique cells are labelled with magnetic 
nanoparticles, that increase in temperature when subjected to an alternating current 
magnetic field (e.g. generated in copper coils  integrated in a microchip [26]), thus causing 
temperature denaturation of the target cells. MFH has also been applied for inactivation of 
bacteria [27]. A summary of the main thermal characteristics of these systems is presented in 
Table 1. 
 
Modular platforms, based on the “plug-and-play” approach, enable the connection of 
independently developed microfluidic units which can be combined or arranged differently, 
depending on the application, type of sample or reaction [28–33]. 
In order to obtain a reliable result when performing enzymatic reactions, it is necessary for 
the samples to be quantified at the same or at a well-defined reaction time point. The 
quantification of reaction components under flow conditions (as part of a continuous operation 
platform) requires a comprehensive characterization of the microreactor so that samples 
obtained at different reaction times can be compared. However, in a modular platform, where 
the reactor and operation units can be changed, it is essential that samples reach the 
quantitative system or sensor in the same conditions. Enzymatic reactions can be stopped 
through addition of reagents that inactivate the enzyme or through compounds that block the 
active site, but this may interfere with the operation of the sensor used for the quantification 
(e.g. addition of NaOH or HCl for pH change and enzyme denaturation can destroy the 
biosensing layer of electrochemical-based sensors). 
 
The microfluidic platform presented was developed as an intermediary step in a modular 
microfluidic platform and intended to address the latter issue by providing an alternative 
inactivation strategy: temperature-based enzyme inactivation. Temperature allows an 
unspecific inactivation of both enzymes and cells, also enabling reversible or irreversible 
inactivation of the proteins involved depending on the chosen operation conditions, offering a 
further degree of control on the enzyme state during operation. Temperature is also used in 
different fields, and so its integration in a modular platform increases the platform’s 
applicability by different users. The platform’s inactivation ability was compared with the 
standard laboratory method in order to validate its usefulness as part of an enzymatic 
screening platform. 
 
In this work, a new microfluidic platform for thermal inactivation of enzymes was fabricated 
and its inactivation ability compared with a standard laboratory procedure, a table top orbital 
heating device. The time required to achieve the desired inactivation temperature was 
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simulated in parallel using computational fluid dynamics for further validation of the 
fabricated platform. 
 
Materials and Methods 
Reagents and Materials 
Glucose oxidase (EC 1.1.3.4, type VII, from Aspergillus niger, ≥100,000 U/g solid), catalase (EC 
232-577-1, from bovine liver, lyophilized powder, 2000-5000 units/mg protein), horseradish 
peroxidase (EC 1.11.1.7, lyophilized, 150 U/mg),  hydrogen peroxide (PerdrogenTM, 30% (w/w)), 
sodium 3,5-dichloro-2-hydroxy-benzenesulfonate (DCHBS) and 4 -aminoantipyrine (4-AAP, 
reagent grade) were  from Sigma (St. Louis, MO, USA). D- glucose (anhydrous) was from 
Fluka (Loughborough, UK). Mono – and di-potassium hydrogen phosphate (anhydrous) were 
from Merck (Darmstadt, Germany). All the solutions for sensor preparation were prepared 
with 50 mM phosphate buffer pH 7.5. All solutions were prepared in buffer. 
 
The 10-mm marlon polycarbonate plate that forms the channel was from Brett Martin 
(Newtownabbey, UK). The 2-mm thick SS304 stainless steel bottom plate of the channel, as 
well as the structural components of the platform were from Sanistål (Aalborg, Denmark). The 
polycarbonate and steel parts were milled using an ecoMill 50 from DMG mori (Bielefeld, 
Germany). The adhesive assembly of the platform was performed with a 142 µm thick double-
sided adhesive tape mcs-foil 008 from microfluidic ChipShop (Jena, Germany), previously 
patterned using laser ablation with a CMA-4030 Laser Engraving machine from GD Han’s 
Yueming Laser Technology co., Ltd (Guangdong, China). Flangeless polypropylene (PP) 
fingertight 1.5875 mm (ID) fittings (XP-201) and flangeless ferrules (P200X) from Upchurch 
Scientific® (Washington, USA) were used to connect polytetrafluoroethylene (PTFE) 1.5875 
mm (OD) x 1mm (ID) tubing (S 1810-12) from Bohlender (Grünsfeld, Germany). 
Enzyme activity measurements 
Activity measurements of glucose oxidase (GOx) and catalase (Cat) were performed in a UV-
1800 UV-Vis spectrophotometer with a CPS 240A cell positioner from Shimadzu (Kyoto, 
Japan). GOx activity was measured using a protocol adapted from Heuts et al.  [34], in which 
10 µL of 1:30 diluted GOx solution (~30 U/mL) were added to 990 µL of the reaction mixture. 
For the inactivation study, the initial rates of glucose consumption / colorimetric compound 
formation were compared for a glucose concentration (400 mM) around 10 times the measured 
KM (~30 mM). The activity of Cat (~400 U/mL) was measured based on the protocols by Beers 
and Sizer  [35] and H. Lück  [36], in which 30 µL of 1:10 diluted Cat solution was added to 
2970 µL of 10 mM hydrogen peroxide. Each spectrophotometric measurement was performed 
in triplicate for 2 min. 
Thermal inactivation platform 
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The microfluidic thermal inactivation platform has several components, as shown in Figure 1. 
The microfluidic channel was micromillled in a polycarbonate plate with a meander shape, 
with 150 µm depth and 790 µm width, as well as a pocket for a temperature sensor 
(Figure 2 (a)). The microchannel has two main inlets (forming the primary channel) and two 
side inlets (forming the secondary channel), which provide a wider range of residence times. 
The polycarbonate plate was glued onto a thin stainless-steel plate with a patterned double 
sided adhesive tape, giving the channel an overall height of 292 µm. A PT 1000 temperature 
sensor (Platinum Thin Film PTFM102A1A0 from Measurement Specialties (Europe) Ltd., 
Dortmund, Germany) was placed in contact with the steel plate and connected to a controller 
(Laird PR-59 Advanced Temperature Controller from Supercool AB, Stromstad, Sweden) 
which was operated from a personal computer (PC). The controller had an EOS LFWLP350-
1005 power supply (EOS, Andheri, Mumbai, India). The Peltier elements from Multicomp by 
Newark element14, Chicago, Illinois, USA have a dimension of 40mmx40mmx3.45mm, a 
maximum temperature differential of 70 K during cooling, and can be controlled with software 
(SC_Interface) provided with the controller. Before assembly the Peltier elements were 
covered with a thin layer of a heat transfer paste (HTS Silicone Heat Transfer compound from 
Electrolube, Leicestershire, UK). To facilitate the cooling of the cool side of the Peltier 
elements during operation, a heat sink and a fan were connected to the microchannel 
assembly. The assembled Peltier elements were placed on the heat sink structure, which was 
milled in order to have the shape of the Peltier elements and enable a good fit of the 
microchannel assembly onto the heat sink (60mmx40mmx10mm, 153AB from ABL Aluminum 
Components, Birmingham, UK). The fan (614 NGL DC axial fan from Ebm-papst Inc., 
Farmington, Connecticut, USA) was assembled underneath the heat sink and connected to the 
controller. The connection of the electronic components was performed in-house, and installed 
inside a 30 cmx 30 cm x 10 mm plastic box. The characterization of the thermal performance 
of the developed inactivation platform is presented in the supplementary material. 
 
Thermal inactivation measurements 
The study of the enzymatic inactivation ability of the assembled microfluidic platform was 
performed for each enzyme separately, as presented in Figure 3, by pumping the enzyme 
solution inside the channel at different flowrates to achieve the desired residence times and 
temperatures (presented in Table 2). Before introduction of the enzyme solution, the channel 
was heated to the desired inactivation temperature, and flushed with enzyme solution (Re 
2.05) for a minimum of 6 times the channel volume before sampling. The enzyme solution was 
then retrieved at the outlet, appropriately diluted and measured in the spectrophotometer. 
GOx solutions were also added to a vial with 200 mM glucose solution in a 1:1 proportion, and 
glucose concentration was measured after 1 and 2 d in a high-throughput liquid 
chromatographer (HPLC) Dionex UltiMate 3000 UHPLC system with diode array and 
refractive index detector (Thermo Fisher Scientific, Waltham, Massachusetts, USA). HPLC 
data was used to check whether inactivation or denaturation occurred in the platform. In the 
case of Cat, the same solutions retrieved at the outlet of the microchannel were measured 
after 1 d in the UV/VIS spectrophotometer and hydrogen peroxide consumption was compared 
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to that of freshly inactivated enzyme. The samples of both enzymes were kept at room 
temperature following inactivation. 
 
The same study of the enzymatic inactivation ability was performed in a tabletop orbital 
MRH11 Heating ThermoMixer (HCL BioTech, Bovenden, Germany), for the same 
temperatures and residence times as for the microfluidic system. In this case, 500 µL of the 
enzyme solution were added to a 4-mL vial that was already at the target inactivation 
temperature. The consumption of glucose by the enzyme solutions inactivated in the 
ThermoMixer was also measured in the HPLC after 2 d. In both sets of experiments, GOx 
solutions were freshly prepared, while Cat solutions were diluted from a stock solution (~1000 
U/mL) daily. The activity of Cat in the stock solution was measured daily. The enzymes were 
kept on ice (around 277 K) during the experiments and added to the ThermoMixer and to the 
channel only when these were heated at the inactivation temperature being tested. 
 
Characterization of thermal inactivation platforms with computational fluid dynamics 
(CFD)  
The microchannel and 4-mL vial geometries were designed in SolidWorks 2015 (Dassault 
Systèmes SolidWorks Corporation, Waltham, Massachusetts, USA). The time required to 
achieve the final inactivation temperature from room temperature (298 K) was simulated 
using a computational fluid dynamic simulation software, ANSYS-CFX Version 16.2 
(Canonsburg, Pennsylvania, USA). The three-dimensional designs of the microchannel 
(Figure 2 (a)) and 4-mL vial (Figure 4 (a)) were imported into a meshing software, ANSYS 
ICEM CFD® 16.0 (Canonsburg, Pennsylvania, USA), and discretization of the geometry into 
smaller elements (where the equations for momentum, energy and mass balance [37,38]are 
solved by ANSYS-CFX software) was performed. The geometry of the 4-mL vial was simplified 
based on an axial geometry to a slice of 1.24% of the entire volume, corresponding to the 
volume of 5⁰ of the cylinder vial perimeter (Figure 4 (b)). The slice defined contained 11284 
mesh elements (107.5 elements/ µL). The microchannel geometry was simplified to a straight 
30 cm long channel with one quarter of the width of the actual microchannel and defined with 
steel underneath and a 5-mm polycarbonate plate on top (Figure 2 (b)) containing 72144 
elements (2312.3 elements/ µL). Both designs were simulated with a structured hexahedron 
mesh, assuming that the structures and the environment were at 298 K. In order to simulate 
the whole structure, symmetry was assumed on both sides of the slice (axial symmetry) and 
microchannel design. When symmetry is used, the conditions on the areas beyond the 
simulated volume are a reflection of the simulated conditions. The use of symmetry enables  
reduction of the computational time required for the simulation [38]. The fluids were 
simulated according to the Navier-Stokes equation for Newtonian fluids [39] under laminar 
flow conditions, which was solved coupled with the energy balance [40] using the Thermal 
Energy model integrated in ANSYS-CFX.  
 
The vial was considered to be made of glass, with a height of 9 mm corresponding to the liquid 
and the rest was filled with air. The three phases, solid (glass), liquid (fluid) and gas (air), 
were defined as separate parts in the geometry with a conservative interface flux condition, 
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where only temperature is conducted between the solid and the liquid phase. In both the 
liquid and the air phases, two fluids were defined: water with a density of 997 Kg m-3 and air 
with a density of 1225 Kg m-3. In the air phase, air had an initial volume fraction of 1 and 
water of 0, while in the liquid phase, the opposite was set. Both fluids were defined as buoyant 
with 9.81 m s-2 as the gravitational acceleration towards the bottom of the vial. The heat was 
defined as coming only from the glass outer walls (bottom and side of the vial) as presented in 
Figure 4 (b). The portion of liquid on the bottom was at 277 K at the start of the simulation, 
while the air above it was at 298 K.  
 
The microchannel (Figure 2 (b)) was filled with liquid under laminar flow with a flow velocity 
of 0.025 m/s (Re 5.60), 0.0025 m/s (Re 0.56) or 0.0018 m/s (Re 0.40), and the heat was defined 
as coming from the bottom of the channel as in Figure 2 (b). All the materials were simulated 
considering their properties provided by ANSYS-CFX at 298 K, and the liquid was defined as 
water. The polycarbonate plate was simulated as polystyrene with a specific heat capacity of 
1426 J/Kg.K. The walls (top and bottom of the channel) were defined as having no-slip wall 
boundary conditions, and the outlet was defined as an opening. The simulations were 
performed as transient in order to obtain the time required for both the liquid and the entire 
system to reach the target inactivation temperatures.  
Results and Discussion: 
The thermal inactivation platform was characterized using two well-known and relatively 
robust commercially available enzymes, GOx and Cat. Both are relatively stable and present 
enzymatic activity over a wide range of temperatures (293 K to 333 K for GOx and 303 K to 
333 K for Cat), thus providing a good case study to test the efficiency and applicability of the 
developed inactivation platform.  
The platform’s performance was compared with a standard laboratory procedure used to 
achieve thermal enzyme denaturation, a benchtop ThermoMixer. The temperatures and 
residence times presented in Table 2 were used in both platforms. 
 
In this work, the term enzymatic inactivation will refer to the reversible or irreversible loss of 
functional activity of proteins. The term enzymatic denaturation will be applied when there is 
inactivation of an enzyme due to an alteration of its conformation [41]. When there is 
irreversible loss of enzymatic functional activity, the term enzymatic deactivation will be 
applied.  
Characterization of heating performance with CFD 
A simplified geometry of both systems used to achieve enzymatic thermal denaturation of GOx 
and Cat was characterized in terms of time required to reach the target temperature using 
computational fluid dynamics. Three of the target inactivation temperatures, 298 K, 318 K 
and 353 K, were chosen for comparison of heating performance in the two simulated 
inactivation systems. 
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 Figure 5 (a) presents the temperature contour plot of the liquid being heated to 353 K at the 
same residence times used in the experiments. Only part of the liquid is first heated to the 
target temperature (353 K) after 120 s of exposure, while uniform heating of the liquid to 
353 K is achieved around 180 s, which corresponds to the longest residence time used for 
enzyme inactivation in this study. This indicates that the enzyme solutions inactivated in the 
ThermoMixer were not uniformly exposed to the same temperature for the shorter 
inactivation times and so higher variability might be expected from these samples, since no 
mixing was used. 
 
As observed in Figure 5 (a) and (b), for 318 K and 298 K respectively, the liquid achieves the 
target temperature earlier than for 353 K. The target temperatures are achieved between 60 s 
and 120 s after sample heating is initiated for 298 M and 318 K, and thus variability for the 
corresponding samples at residence times above 120 s should be very small. Comparing 
heating times for Figure 5 (a), (b) and (c) the lower the target temperature, the shorter the 
time required to reach the desired temperature. However, the wider the temperature 
difference between initial conditions (sample at 277 K and air at 298 K) and inactivation 
temperature (298 K, 318 K and 353 K), the faster the heating rate.  This is evident in Figure 5 
(a) where a temperature of 318 K is obtained between 30 s and 60 s, which is consistent with 
the higher temperature gradient and therewith a higher driving force for the heat transfer to 
occur in this case (353 K).  
 
The results from the CFD simulation for the simplified geometry of the microchannel are 
presented in Figure 6. In this geometry, we considered that the bottom of the microchannel 
(which corresponds to the steel plate) is at an initial temperature of 353 K, 318 K or 298 K, 
when the enzyme solution at 277 K is introduced in the microchannel with a linear velocity of 
0.0018 m/s (Re 0.40).  
 
As can be observed for the inactivation temperature of 353 K (Figure 6 (a)), the liquid flowing 
inside the channel reaches the desired temperature after 0.6 s. This significantly faster 
heating of the enzyme solution relative to the 4-mL vial (Figure 5 (a)) is expected, considering 
the microchannel’ s small height (292 µm) and reduced volume, which enables a fast heat 
transfer from the steel plate to all transported fluid. The required time for the fluid to reach 
the chosen inactivation temperature decreases for lower temperatures, as can be observed in 
Figure 6 (b) and (c). However, as observed above (Figure 5)  for the 4-mL vial, the same 
temperatures (318 K and 298 K) are reached earlier in the 353 K case (at 0.3 s the fluid is 
already between 338 K and 353 K) than for the lower temperatures since the temperature 
gradient (and thus heat transfer rate) is higher.  
 
It is also relevant to highlight that the inactivation temperature is reached close to the start of 
the channel, as can be observed in the focused regions in Figure 6 (a) and (b). This means that 
the enzyme solution is exposed to the desired inactivation temperature through the entire 
length of the microchannel, and thus that the residence times considered during the 
experiment are close to the real ones. The distance from the inlet at which the entire volume 
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of transported solution reaches the inactivation temperature also decreases with decreasing 
inactivation temperatures, from 700 µm for the simulation at 353 K to around 550 µm at 318 
K and 0 µm at 298 K.  
 
To enable the comparison with laboratory enzyme inactivation experiments performed in the 
microchannel, CFD simulations at 353 K were performed at different average linear flow 
velocities between 0.0018 m/s and 0.025 m/s, to include the range of velocities used in the 
laboratory experiments (see Table 2). No significant difference was observed in the overall 
temperature distribution or the times at which the set point temperature was reached 
between the different velocities. However, the distance from the inlet at which the whole 
liquid reaches 353 K increases with an increase in flow velocity. This occurs since there is less 
time due to the fluid’s higher velocity for the heat to diffuse across the height of the channel to 
the solution, as well as some drag of the heat in the direction of the flow (Figure 7). At the 
lowest simulated velocity this distance is 700 µm, while at the highest simulated velocity the 
distance is close to 8 mm. For the maximum experimental velocity (0.0087 m/s) this distance is 
below 3 mm, which is around 1/30 of the length of channel used (87 mm), and thus its 
influence in the final used residence time was not considered for the performed experiments. 
The simulations presented here provide sufficient confidence that the enzyme solution will be 
uniformly exposed to the inactivation temperature along the entire length of the channel (and 
close to the assumed residence time).  
 
In all the simulations, after 10 min the distribution of temperature in the microchannel is 
approximately the same as the one observed after 1 h, with the temperature at the top of the 
polycarbonate plate at 298 K. During the experiments however, after approximately 10 to 15 
min the top of the polycarbonate plate was hot to the touch. This discrepancy could come from 
the polycarbonate properties (namely the specific heat capacity) assumed during the 
simulation, which could differ from those of the polycarbonate used for the microfluidic plate. 
The temperature during the experiments may also be higher than those simulated. However, 
since the heat provided by the Peltier elements is regulated based on the temperature 
measured by the PT 1000 sensor, and this sensor is placed close to the channel, this is not 
expected to be the case. In the simulations, the area surrounding the channel forming most of 
the platform, as well as the possible influence of the double adhesive tape between the steel 
and the polycarbonate plate were not considered. These factors might also affect how heat 
dissipates from the platform, thus influencing the temperature reached on the outside of the 
platform.  
 
Nevertheless, since the focus of the CFD simulation was to understand the heat transfer to 
the enzymatic solution flowing inside the channel, which was possible to visualize in the 
simulations performed, the simulation was considered to have yielded enough understanding 
of the heating properties of both inactivation strategies to be able to trust the design of the 
microfluidic system developed.  
Characterization of inactivation performance  
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The results from the spectrophotometric measurements performed after the enzyme solutions 
were sampled from the ThermoMixer or pumped through the microfluidic channel at various 
residence times and inactivation temperatures are presented in Figure 8, both for GOx and 
Cat. The presented values have a standard deviation between 3.87*10-9 M/min and 8.66*10-7 
M/min for GOx and 2.90*10-6 M/min and 1.29*10-4 M/min for Cat. 
Both enzymes display a similar inactivation trend. At 338 K or higher temperatures, a 
significant decrease in product formation/ hydrogen peroxide consumption is observed in both 
systems, especially for residence times higher than 60 s. In the ThermoMixer complete 
inactivation of the enzymes is observed at 353 K for residence times of 120 and 180 s. This is 
in agreement with the simulations in Figure 5, where only for these residence times the 
temperature inside the vial is closer to the desired temperature. In the microchannel, enzyme 
inactivation occurs at lower temperatures than 353 K. In this system, at 338 K and residence 
times of 120 s and 180 s almost no activity is observed. This is a good indication that the whole 
volume of the enzyme solution has been subjected to the same temperature for the defined 
residence time in the microchannel, as supported by the simulations performed.  
 
Both enzymes seem to behave similarly in terms of inactivation at the temperatures used, 
although a faster inactivation of Cat was to be expected since it is known to be the less stable 
of the two enzymes [42]. GOx inactivation is known to occur through loss of its co-factor 
(FAD), which happens around 332 K, followed by loss of conformation above 335 K (mid-point 
for loss of secondary and tertiary structure, according to  [43]. This mid-point of conformation 
loss may even occur at a lower temperature (328 K) [44]. The values obtained during the 
experiments agree with the previous temperatures, since the amount of product at 338 K is 
around half of the values obtained at 328 K, and a rapid decrease in activity is observed at 338 
K. Cat, such as GOx, is prone to denaturation for temperatures above 328 K [45], due to a 
process of protein denaturation [46,47]by dissociation of its subunits [42]. 
 
The thermal inactivation platform is intended for use as an intermediary step between 
reaction and quantification, and so should guarantee that the reaction has stopped at the 
desired residence time before the measurement is performed. Since the measurements 
performed immediately after inactivation (as would occur in the modular platform) at 353 K 
showed no activity for both enzymes, Cat and GOx, this goal seems to have been achieved. 
Characterization of deactivation ability  
To check the stability of the inactivation, whether reversible inactivation or deactivation of the 
enzymes was achieved in the platform, the activity of the inactivated enzyme solutions was 
measured after one (Cat) and two days (GOx). The substrate concentration measured through 
HPLC for the different samples obtained is presented in Figure 9 (a). Between measurements, 
samples were kept at room temperature (~298 K). As can be observed in Figure 9 (a), samples 
that flowed inside the microfluidic system consumed less than 10 mM of glucose after 1 and 2 
days, while samples inactivated in the ThermoMixer, consumed almost all the glucose present. 
This may indicate that a partial irreversible denaturation of GOx occurred in the microfluidic 
platform, while in the ThermoMixer the enzyme was able to return to the active state after 
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exposure to the inactivation temperatures and used residence times. For the latter, it was also 
noticeable that samples inactivated at 298 K and 310 K presented a higher overall variability 
between them, especially at the shorter residence times. This might be related to the observed 
non-uniform temperature distribution in the simulations performed for the 4-mL vial at the 
shorter residence times.  
 
In Figure 9 (a), a significant deactivation of GOx was observed for all the inactivation and 
residence times tested, even for temperatures below FAD dissociation (332 K, according with 
[43]). Thus, for temperatures below 332 K, GOx deactivation may be caused by other 
phenomena besides temperature, leading to loss of conformation (e.g. hydrophobic interactions 
with channel walls). On the other hand, Zoldák et al. [44] observed that irreversible 
denaturation of GOx occurred if upon inactivation at 328 K the enzyme solution was 
immediately cooled to 293 K. They also observed that dissociation of the co-factor and of the 
protein dimer occurred after the inactivation rate limiting step [44]. This may explain in part 
the observed deactivation for the temperatures below 328 K, but other phenomena may be 
involved in the extent of detected denaturation, since no significant difference is observed 
between the several inactivation temperatures tested in terms of substrate consumption. 
 
The inactivated Cat solutions were kept at room temperature overnight and consumption of 
hydrogen peroxide was measured in the spectrophotometer the following day (Figure 9 (b)). 
Samples demonstrated a return of activity for those inactivated at temperatures up to 318 K, 
and loss or even no activity for samples inactivated at higher temperatures for 180 s.  Activity 
of Cat pumped through the microfluidic system was lower for 338 K and 353 K than that 
inactivated in the ThermoMixer, since some substrate consumption was measured for the 
latter samples. The occurrence of deactivation in both systems might be related to the 
previously mentioned lower stability of Cat relative to GOx, thus translating into a smaller 
difference in deactivation between the two inactivation strategies. Furthermore, Cat solutions 
from both inactivation systems formed aggregates overnight, especially for the higher 
residence time (180 s) and inactivation temperatures (338 K and 353 K). Protein aggregation 
indicates loss of conformation due to denaturation, and thus enzymatic deactivation, which is 
in agreement with the very low substrate consumption measured for these conditions. Cat 
deactivation associated with protein aggregation is a known phenomenon [48]. 
 
Nevertheless, for both enzymes a decrease in enzyme activity was observed with increasing 
temperature, along with significant difference in substrate consumption between the samples 
inactivated in the ThermoMixer and in the microfluidic platform. The observed deactivation 
phenomenon seems to depend on the type of enzyme, since GOx deactivation occurred mainly 
in the microchannel at all the temperatures used (possibly due to hydrophobic interactions 
with the channel), while Cat deactivation occured mainly due to the effect of temperature. 
However, for both enzymes, a high degree of deactivation for the duration of the assay was 
observed. 
 
The observed partial deactivation for both enzymes in the microfluidic system could be 
influenced by other factors such as the closer proximity of the transported enzyme to the heat 
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source (steel plate forming the bottom of the channel), a more uniform temperature 
distribution, time controlled exposition to the desired inactivation temperature, and 
considerably faster heat transfer to the solution (0.6 s instead of 178 s according to the 
simulations). Furthermore, the platform has a layer of double sided adhesive tape between the 
steel bottom plate and the channel polycarbonate plate, thus forming part of the walls of the 
channel. During fluid flow the enzyme may have been exposed to residues of adhesive from 
this tape, which could further contribute to denaturation. However, since the two enzymes 
performed differently when pumped inside the system (aggregation in the case of Cat but not 
GOx, for example), this is probably not a significant factor. 
 
The Peltier elements together with the integrated PT 1000 sensor provide a good control of the 
applied temperature, enabling a simple setup for thermal inactivation studies.  Integration in 
a modular platform is facilitated by using standard inlet finger tight connectors, but also by 
designing the meander channel with dimensions compatible with most commercial 
microfluidic systems. Furthermore, the inclusion of two channels with different lengths 
increases the flowrates and thus the number of different inactivation times possible for the 
platform, further increasing its flexibility towards different reactor or sensing modules.  
Conclusion: 
The thermal inactivation platform described is capable of achieving rapid inactivation of 
mesophilic enzymes, such as GOx and Cat. Inactivation is achieved in this system at 
temperatures around the mid-point of inactivation at relatively long exposure time (120 s at 
338 K) or at a higher temperature in a duration compatible with continuous inactivation of 
enzymes coming from a reactor module (20 s at 353 K). Furthermore, the system causes 
significant deactivation of both enzymes towards a possibility for storage of the enzymes 
without the reaction proceeding significantly. The continuous thermal inactivation platform 
has an improved performance relative to the standard inactivation method at laboratory scale, 
a benchtop ThermoMixer, since inactivation is achieved faster with the inactivation platform 
for both enzymes and with a lower residual activity. The characterization of temperature 
distribution and heating efficiency of both inactivation methods with CFD, also showed a 
faster heating rate and uniform temperature distribution for the developed microfluidic 
system. The simulations also demonstrated that the introduced fluid is heated to the 
inactivation temperature within 3 mm of the channel length for all the experimental flow 
velocities. The assumed inactivation times can thus be considered as close to the real 
inactivation exposure times that the enzymes experienced.  
 
Control of the reactivation process could be a further advantage with this system, if upon 
collection at the outlet or by coupling with another microchannel, a solution with denaturing 
agents is added to the enzyme in order to avoid formation of covalent bonds and thus 
irreversible enzyme denaturation. The ability to control both inactivation and reactivation, 
especially in a continuous format is very interesting in terms of application, and could be 
tested using the presented platform. The continuous enzymatic thermal inactivation system 
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could also be used to perform reactions at well-controlled temperatures, allowing introduction 
or removal of reaction components through the secondary channel. The platform could be 
further applied to the characterization of enzyme activity at different temperatures, by 
coupling the system with an online sensor for a reaction product, or even a camera if a 
colorimetric assay is used, since the system is transparent. By inverting the position of the 
Peltier elements, in order to achieve temperatures below ambient temperature or even below 
273 K, characterization of psychrophilic enzymes could be performed. On the other hand, by 
changing the Peltier elements to other thermoelectric modules with a wider temperature 
difference between the cool and the hot side, characterization of thermophilic enzymes could 
also be attained, greatly extending the applicability of this module.  
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Figure legends 
Figure 1 – Schematics and photograph of the assembled microfluidic platform for thermal 
inactivation of enzymes, with the different components highlighted. In the photograph 
emphasized with blue dots the inlet and outlet of the main channel, while in green the inlet 
and outlet of the secondary channel are signalled. 
 
Figure 2 – Schematics of polycarbonate plate with engraved microfluidic channel (a) where the 
primary (in blue) and secondary (in green) inlets are highlighted, and schematics of the 
microfluidic channel used in the CFD simulations (b), where flow direction, position of the 
microchannel and heating are highlighted. 
  
Figure 3 – Schematics of sampling in the microfluidic thermal inactivation platform. 
  
Figure 4 – Schematics of 4-mL vial designed in SolidWorks with the slice used for CFD 
simulations shown (a) and simulated slice of 4-mL vial with different parts and heating 
highlighted (b). 
  
Figure 5 - Results from the CFD simulation of part of the 4-mL vial considering the glass was 
pre-heated at 353 K (a), 318 K (b) and 298 K (c) for the different residence times used. 
  
Figure 6 - Results from CFD simulation of the simplified geometry of the microchannel 
considering the bottom of the channel is heated at 353 K (a), 318 K (b) and 298 K (c) and the 
average linear flow velocity is 0.0018 m/s. 
  
Figure 7 - Results from CFD simulation of the simplified geometry of the microchannel 
considering the bottom of the channel is heated at 353 K for different flow velocities. 
  
Figure 8- Amount of colorimetric product formation by GOx and hydrogen peroxide consumed 
by Cat, measured in the spectrophotometer immediately after inactivation in the 
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ThermoMixer ((a) for GOx and (c) for Cat) and microfluidic platform ((b) for GOx and (d) for 
Cat)  
Figure 9 – Substrate consumed by the static and in flow inactivated enzymes (GOx (a) and Cat 
(b) after 1 and 2 days. The black line represents the maximum value of glucose (a) consumed 
by the enzyme solutions inactivated in the microfluidic system. Samples of 20 s inactivation 
times were only measured for the higher temperatures (328 K, 338 K and 353 K) used in the 
microfluidic thermal inactivation platform.  
 
 
 
 
 
 
 
AC
CE
PT
ED
 M
AN
US
CR
IPT
  
 
 
 
AC
CE
PT
ED
 M
AN
US
CR
IPT
  
AC
CE
PT
ED
 M
AN
US
CR
IPT
  
 
AC
CE
PT
ED
 M
AN
US
CR
IPT
  
AC
CE
PT
ED
 M
AN
US
CR
IPT
  
 
 AC
CE
PT
ED
 M
AN
US
CR
IPT
  
 
 
Table 1 – Summary of main thermal properties and applications of several heating strategies at the microscale. 
Heating strategy 
Heating/ 
Cooling rate 
(K/s) 
Temperature 
range (K) 
Response 
time 
Application 
(Thin-film) resistors 5 - 20 298 – 383 
1 s - 3 min 
PCR [38], [22], [23], lab-on-a-disc [24], 
protein synthesis [21] 
Thermoelectric modules 
(TEM) 
20 - 100 270 – 393 
PCR [38], [27], [26], thermal 
management [39] 
Microwave (MW) 
heating 
5 - 30000 298 – 368 ms - s 
PCR [20], Hydrogel polymerization [31], 
Flow chemistry/drug discovery [29] 
Infrared (IR) heating 10 - 65 298 – 368 ms - s 
PCR [32], [38], [33], Enzyme inactivation 
[37] 
Radio-frequency (RF) 
heating 
- 298 – 373 - MHF [34], inactivation of bacteria [36] 
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 Table 2 – Residence times and temperatures used for the characterization of the microfluidic thermal inactivation platform and 
comparison with the ThermoMixer. 
Channel Residence time (s) Flow velocity (ms-1) Temperature (K/⁰C) 
Secondary channel 
(~87 mm) 
10 0.0087 298/25 
20 0.0043 310/37 
30 0.0029 318/45 
Main channel 
(~325 mm) 
60 0.0054 328/55 
120 0.0027 338/65 
180 0.0018 353/80 
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